Opinions Gordon Reid
LiquidiaLQDATOP PICKMar 10, 2026
Gordon ReidOwned
$38.83
Stock price when the opinion was issued
$78.90
As of Jul 02, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
A small company involved in a rare lung disease, PAH. He made money off a similar situation in United Therapeutics, but LQDA has a better drug that is taking share from UT. So, he switched horses.
(Analysts’ price target is $53.75)